Top Markets
Coin of the day
Lexaria Bioscience Corp. Lexaria Bioscience Corp.

Lexaria Bioscience Corp.

LEXXW
주식 순위 #41277
Lexaria Bioscience Corp. is a biotechnology firm specializing in the creation... Lexaria Bioscience Corp. is a biotechnology firm specializing in the creation and licensing of its patented drug delivery system, DehydraTECH. This innovative technology functions by integrating fat-soluble compounds or active pharmaceutical ingredients (APIs) with particular long-chain fatty acids and specific carrier substances. The aim of this process is to significantly boost their entry into the bloodstream, consequently enhancing their effectiveness, enabling lower overall dosages, and supporting healthier methods of oral consumption. DehydraTECH can be utilized with a broad spectrum of active molecules, including fat-soluble vitamins, pain relievers, hormones, PDE5 inhibitors, antiviral agents, oral nicotine and its analogues, and various cannabinoids. The company is also investigating DehydraTECH's potential therapeutic applications for conditions such as high blood pressure, cardiovascular diseases, and diabetes. Its versatility renders it suitable for integration into diverse product categories, encompassing pharmaceuticals, nutraceuticals, over-the-counter remedies, and consumer packaged goods. Established in 2004, Lexaria Bioscience Corp. is headquartered in Kelowna, Canada.
주가
$0.0012
마지막 동기화: 2026-01-13
시가총액
$29.83K
변동 (1일)
-77.36%
변동 (1년)
-98.91%
국가
US
거래 Lexaria Bioscience Corp. (LEXXW)

카테고리

Lexaria Bioscience Corp. (LEXXW)의 주식 분할 이력
Lexaria Bioscience Corp. 주식 (심볼: LEXXW)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 13, 2026에 발생했습니다.
Aug 13, 2026 이전에 매수한 LEXXW 주식 1주는 현재 0주의 LEXXW 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE